MMED MiniMed

$20.15

MiniMed (MMED) is confirmed to report earnings on September 1, 2026, before the market open. The consensus earnings estimate is $0.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +58.4% since its last earnings release on June 3, 2026.

MiniMed Missed Consensus Estimates, Sees Revenue Above Estimates
Wednesday, June 3, 2026 · 6:46 AM ET
Earnings Date
1st Quarter, Jul 2026
Sep 1
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs $0.09
Rev est $828.02M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $16.21

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MiniMed

MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries.

Sector

Healthcare

Industry

Medical Appliances/Equipment